Cavu Management, LP is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 4 open-market trades across 3 companies since 2022, most recently 2023-11-29.
CIK 0001813270
2 open-market purchases totalling $2.0M since 2022, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.